(Q27023013)

Bulent Ozpolat

series ordinal

2

1 reference

Anil K. Sood

series ordinal

3

1 reference

Gabriel Lopez-Berestein

series ordinal

4

1 reference

language of work or name

1 reference

December 2013

1 reference

Journal of Drug Targeting

published in

1 reference

volume

21

1 reference

issue

10

1 reference

page(s)

904-13

1 reference

Albumin-bound formulation of paclitaxel (Abraxane ABI-007) in the treatment of breast cancer

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4057038

Renal clearance of quantum dots

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4057038

Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4057038

In vitro selection of RNA molecules that bind specific ligands

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4057038

Antibody therapy of cancer

21 March 2017

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4057038

21 March 2017

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4057038

Ultrasound triggered release of cisplatin from liposomes in murine tumors

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4057038

A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4057038

Cancer treatment and survivorship statistics, 2012

21 March 2017

1 reference

https://api.crossref.org/works/10.3109/1061186X.2013.837469

Delivery of macromolecules into living cells: a method that exploits folate receptor endocytosis

22 April 2017

1 reference

https://api.crossref.org/works/10.3109/1061186X.2013.837469

MicroRNA-132–mediated loss of p120RasGAP activates the endothelium to facilitate pathological angiogenesis

22 April 2017

1 reference

https://api.crossref.org/works/10.3109/1061186X.2013.837469

The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44

22 April 2017

1 reference

https://api.crossref.org/works/10.3109/1061186X.2013.837469

Phase II study of dose-adjusted EPOCH and rituximab in untreated diffuse large B-cell lymphoma with analysis of germinal center and post-germinal center biomarkers

22 April 2017

1 reference

https://api.crossref.org/works/10.3109/1061186X.2013.837469

Nanocarriers as an emerging platform for cancer therapy

22 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4057038

Recent advances with liposomes as pharmaceutical carriers

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4057038

Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles

7 April 2017

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.837469

Aptamers as targeting delivery devices or anti-cancer drugs for fighting tumors

22 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4057038

Enhancing chemotherapy response with sustained EphA2 silencing using multistage vector delivery.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4057038

Dendrimer and cancer: a patent review (2006-present).

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4057038

Discoidal Porous Silicon Particles: Fabrication and Biodistribution in Breast Cancer Bearing Mice

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4057038

Nanoparticles-mediated drug delivery approaches for cancer targeting: a review

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4057038

Global cancer transitions according to the Human Development Index (2008-2030): a population-based study.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4057038

The accumulation of dual pH and temperature responsive micelles in tumors.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4057038

Amplified release through the stimulus triggered degradation of self-immolative oligomers, dendrimers, and linear polymers

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4057038

Chromatographic methods for the determination of therapeutic oligonucleotides

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4057038

Functional roles of Src and Fgr in ovarian carcinoma.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4057038

Stimulus-responsive macromolecules and nanoparticles for cancer drug delivery.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4057038

Strategies in the design of nanoparticles for therapeutic applications

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4057038

Targeted gene silencing using RGD-labeled chitosan nanoparticles

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4057038

Sustained small interfering RNA delivery by mesoporous silicon particles

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4057038

The PHSCN dendrimer as a more potent inhibitor of human breast cancer cell invasion, extravasation, and lung colony formation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4057038

Folic acid-conjugated chitosan nanoparticles enhanced protoporphyrin IX accumulation in colorectal cancer cells

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4057038

Enabling individualized therapy through nanotechnology

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4057038

PEGylated PAMAM dendrimer-doxorubicin conjugates: in vitro evaluation and in vivo tumor accumulation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4057038

Cationic nanoparticles induce nanoscale disruption in living cell plasma membranes

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4057038

Intravascular delivery of particulate systems: does geometry really matter?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4057038

The effect of particle design on cellular internalization pathways

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4057038

Factors affecting the clearance and biodistribution of polymeric nanoparticles.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4057038

Shape effects of filaments versus spherical particles in flow and drug delivery

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4057038

Imaging characteristics of zinc sulfide shell, cadmium telluride core quantum dots

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4057038

Protein nanoparticles as drug carriers in clinical medicine

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4057038

Suspensions for intravenous (IV) injection: a review of development, preclinical and clinical aspects

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4057038

A review of stimuli-responsive nanocarriers for drug and gene delivery

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4057038

Particle shape: a new design parameter for micro- and nanoscale drug delivery carriers

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4057038

Monoclonal antibody 2C5-modified doxorubicin-loaded liposomes with significantly enhanced therapeutic activity against intracranial human brain U-87 MG tumor xenografts in nude mice

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4057038

Designing dendrimers for biological applications

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4057038

VEGF as a therapeutic target in cancer

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4057038

Poly(ethylene oxide)-modified poly(beta-amino ester) nanoparticles as a pH-sensitive system for tumor-targeted delivery of hydrophobic drugs: part 2. In vivo distribution and tumor localization studies

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4057038

Healing sound: the use of ultrasound in drug delivery and other therapeutic applications

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4057038

Analysis of FDA approved anticancer drugs reveals the future of cancer therapy.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4057038

NEGATIVE STAINING OF PHOSPHOLIPIDS AND THEIR STRUCTURAL MODIFICATION BY SURFACE-ACTIVE AGENTS AS OBSERVED IN THE ELECTRON MICROSCOPE.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4057038

PEGylated nanoparticles for biological and pharmaceutical applications

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4057038

Zevalin: the first radioimmunotherapy approved for the treatment of lymphoma

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4057038

Structure and design of polymeric surfactant-based drug delivery systems

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4057038

Long-circulating and target-specific nanoparticles: theory to practice

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4057038

Apoptotic induction in transformed follicular lymphoma cells by Bcl-2 downregulation.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4057038

The changing epidemiology of fungal infections: are the lipid-forms of amphotericin B an advance?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4057038

Recent advances in liposomal drug-delivery systems

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4057038

Preparation and evaluation of thiol-modified gelatin nanoparticles for intracellular DNA delivery in response to glutathione

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4057038

Design principles for clinical efficacy of cancer nanomedicine: a look into the basics

31 May 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.837469

Phase III Trial of Nanoparticle Albumin-Bound Paclitaxel Compared With Polyethylated Castor Oil–Based Paclitaxel in Women With Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.837469

Tumor delivery of macromolecular drugs based on the EPR effect

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.837469

Nanoparticles for drug delivery in cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.837469

The first targeted delivery of siRNA in humans via a self-assembling, cyclodextrin polymer-based nanoparticle: from concept to clinic.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.837469

Transferrin receptor targeting nanomedicine delivering wild-type p53 gene sensitizes pancreatic cancer to gemcitabine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.837469

Bone-protective effects of nonviral gene therapy with folate-chitosan DNA nanoparticle containing interleukin-1 receptor antagonist gene in rats with adjuvant-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.837469

Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.837469

Requirement of vascular integrin alpha v beta 3 for angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.837469

Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.837469

Pegaptanib for neovascular age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.837469

Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.837469

Nanovector delivery of siRNA for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.837469

MicroRNA delivery by cationic lipoplexes for lung cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.837469

Therapeutic Delivery of MicroRNA-29b by Cationic Lipoplexes for Lung Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.837469

Nanoparticles modified with tumor-targeting scFv deliver siRNA and miRNA for cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.837469

Restitution of tumor suppressor microRNAs using a systemic nanovector inhibits pancreatic cancer growth in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.837469

Systemic microRNA-34a delivery induces apoptosis and abrogates growth of diffuse large B-cell lymphoma in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.837469

Lactosylated gramicidin-based lipid nanoparticles (Lac-GLN) for targeted delivery of anti-miR-155 to hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.837469

Design of polymeric nanoparticles for biomedical delivery applications

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.837469

Precision synthesis of biodegradable polymers.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.837469

Polymer therapeutics as nanomedicines: new perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.837469

Polymeric nanoparticles for siRNA delivery and gene silencing

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.837469

The use of nanoparticle-mediated targeted gene silencing and drug delivery to overcome tumor drug resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.837469

Overview of ribonucleotide reductase inhibitors: an appealing target in anti-tumour therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.837469

The transferrin receptor and the targeted delivery of therapeutic agents against cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.837469

Cationic microRNA-delivering nanovectors with bifunctional peptides for efficient treatment of PANC-1 xenograft model

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.837469

Folate receptor targeted biodegradable polymeric doxorubicin micelles

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.837469

More effective nanomedicines through particle design

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.837469

Size and shape effects in the biodistribution of intravascularly injected particles.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.837469

Polymer degradation and in vitro release of a model protein from poly(d,l-lactide-co-glycolide) nano- and microparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.837469

Influence of particle size and dissolution conditions on the degradation properties of polylactide-co-glycolide particles

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.837469

Factors that control the circulation time of nanoparticles in blood: challenges, solutions and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.837469

Macrophage uptake of core-shell nanoparticles surface modified with poly(ethylene glycol).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.837469

Wide varieties of cationic nanoparticles induce defects in supported lipid bilayers.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.837469

Albumin-conjugated PEG liposome enhances tumor distribution of liposomal doxorubicin in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.837469

PLA/PLGA nanoparticles for sustained release of docetaxel.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.837469

Trastuzumab, a humanized anti-HER2 monoclonal antibody, for the treatment of breast cancer.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4057038

FDA approves new kind of lymphoma treatment. Food and Drug Administration.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4057038

Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4057038

Effect of coupling of albumin onto surface of PEG liposome on its in vivo disposition

28 November 2018

1 reference

12 December 2020

Safety, pharmacokinetics, and tissue distribution of liposomal P-ethoxy antisense oligonucleotides targeted to Bcl-2

1 reference

12 December 2020

[Incorporation of physiologically-active substances into a colloidal blood plasma substitute. I. Incorporation of mescaline peptide into polyvinylpyrrolidone]

1 reference

12 December 2020

Attempted targeting of a monoclonal antibody in a human tumour xenograft system

1 reference

12 December 2020

Antibody Targeting of Long-Circulating Lipidic Nanoparticles Does Not Increase Tumor Localization but Does Increase Internalization in Animal Models

1 reference

12 December 2020

Diffusion of univalent ions across the lamellae of swollen phospholipids

1 reference

12 December 2020

Albumin microspheres for study of the reticuloendothelial system

1 reference

12 December 2020

10.3109/1061186X.2013.837469

Identifiers

DOI

1 reference

1 reference

PubMed publication ID

24079419

1 reference